Phathom Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal diseases and disorders.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 05/15/19 | $90,000,000 |
Frazier Healthcare Partners Takeda Pharmaceutical Company | undisclosed |
